Skip to main content
Jason Efstathiou, MD, Radiation Oncology, Boston, MA

Jason A. Efstathiou MD PhD


Professor of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital

Join to View Full Profile
  • Massachusetts General Hospital55 Fruit StreetBoston, MA 02114

  • Phone+1 617-726-5866

Dr. Efstathiou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2004 - 2008
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2026
  • RI State Medical License
    RI State Medical License 2021 - 2026
  • ME State Medical License
    ME State Medical License 2020 - 2025
  • NH State Medical License
    NH State Medical License 2021 - 2025
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer  
    Jason Efstathiou, MD, JAMA
  • Impact of Interfractional Motion on Hypofractionated Pencil Beam Scanning Proton Therapy and VMAT Delivery for Prostate Cancer  
    A L Zietman, Y Wang, J A Efstathiou, F H Khan, Medical Physics
  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features  
    Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA

Authored Content

  • Are We Ready to Change Management Based on Next-Generation Imaging? YES: APCCC 2022 Presentation Jason EfstathiouAugust 2022

Press Mentions

  • Proton Therapy and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
    Proton Therapy and Intensity-Modulated Radiation Therapy for Localized Prostate CancerApril 4th, 2025
  • American Society for Radiation Oncology, Sept. 29-Oct. 2
    American Society for Radiation Oncology, Sept. 29-Oct. 2October 9th, 2024
  • IMRT vs Proton Therapy for Early Prostate Cancer?
    IMRT vs Proton Therapy for Early Prostate Cancer?October 1st, 2024
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: